ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,425, issued on July 29, was assigned to Pfizer Inc. (New York) and CTXT PTY LTD (Melbourne, Australia).
"Benzisoxazole sulfonamide derivatives" was invented by Ylva Elisabet Bergman Bozikis (Parkville, Australia), Michelle Ang Camerino (Parkville, Australia), Pei-Pei Kung (San Diego), Paul Anthony Stupple (Melbourne, Australia) and Scott Channing Sutton (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds of formula (I)or pharmaceutically acceptable salts thereof, wherein Ring A, R1-R8, and n are defined herein. The novel benzisoxazole sulfonamide derivatives are useful in the treatment of abnormal cel...